Sera Prognostics Inc.
PublicSera Prognostics Inc. is now publicly traded
The data on this page reflects Sera Prognostics Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jul 14, 2021
Last Round
Follow-on Offering
Feb 10, 2025
Est. Valuation at Exit
$227.99M
Total Funding Raised
$345.3M
Company Overview
Sera Prognostics Inc. is a health diagnostics company that provides innovative pregnancy biomarker information to doctors and patients to improve maternal and neonatal health.
Verticals
Women's Health, Pregnancy Care, Predictive Diagnostics
AI Layer
Application
Keywords
Sera Prognostics Inc. Comparables
Compare Sera Prognostics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mirvie | 82% | |
| NX Prenatal Inc. | 77% | |
| Milu Labs | 68% | |
Sera Prognostics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Feb 10, 2025 | ||||
| IPO | Jul 14, 2021 | ||||
| Series E | Apr 28, 2021 | ||||
| Series D | Nov 13, 2019 | ||||
| Series C | Jan 10, 2017 | ||||
Grant | Feb 4, 2015 |
Sera Prognostics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jefferies | Follow-on Offering |
| Chione Ltd | Series D, Series B |
| CHV | Grant |
| InterWest Partners | Series C, Series D, Series B, Series A |
| Domain Associates | Series C, Series D, Grant, Series B, Series A |
| Osage University Partners | Series A, Grant, Series B |
| TD Cowen | Follow-on Offering |
Sera Prognostics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
